Walgreens Boots Alliance reported a decrease in earnings per share to 33 cents in the fiscal third quarter, compared with $1.38 in the year-ago quarter. Adjusted earnings per share came in at 96 cents, surpassing analysts’ expectations of 92 cents per share.
The pharmacy retail company’s sales from continuing operations decreased -4.2 percent from the year-ago quarter to $32.6 billion. The company reported a $683 million charge related to its opioid settlement with the State of Florida in the current quarter.
In the U.K., Boots’ comparable sales climbed +24 percent, indicating some recovery in footfall, although store footfall remains around 20 percent below pre-Covid levels.